Longitudinal insights into comorbidity patterns and burden among middle-aged and older adults with diabetes in China: a nine-year cohort study using CHARLS

利用CHARLS数据开展的为期九年的队列研究,深入探讨了中国中老年糖尿病患者的合并症模式和疾病负担。

阅读:3

Abstract

BACKGROUND: China has the largest diabetic population, accounting for over a quarter of global cases. As a chronic condition frequently accompanied by comorbidities, diabetes requires research on the patterns and burdens of associated conditions, particularly within primary care settings. We aim to provide longitudinal insights into the evolution of comorbidity patterns and burdens among China's diabetic population, examining trends and influencing factors. METHODS: We used longitudinal data in five waves (2011-20) of the China Health and Retirement Longitudinal Study (CHARLS). We classified comorbidities into three categories based on their aetiological relationship with diabetes: traditional concordant (TCC), non-traditional concordant (NCC), and discordant (DC). We used generalised estimating equation (GEE) models to identify factors influencing comorbidity burden. RESULTS: Between 2011 and 2020, the prevalence of diabetes among individuals aged ≥45 years in China increased from 6.3% to 17.6%, while diabetes-related comorbidities rose from 5.3% to 16.9%. The most prevalent comorbidities in 2020 were hypertension (68.3%) and dyslipidemia (62.3%). The average number of conditions per diabetic patient increased by 1.5, and the Charlson comorbidity index (CCI) increased by 50%. At the final follow-up, 65.4% of patients had TCC, 92.4% had NCC, and 75.9% had DC. GEE analysis showed that the number (β = 0.034; P = 0.009) and CCI (β = 0.041; P = 0.021) of comorbidities increase with age. Diabetes control was significantly associated with a decrease in both the numbers (β = -0.720; P < 0.001) and CCI of TCC (β = -0.951; P < 0.001), a modest but significant reduction in NCC numbers (β = -0.134; P = 0.021) without a corresponding decrease in its CCI, and no significant association with DC. CONCLUSIONS: The increasing comorbidity burden in diabetic patients highlights the need for primary care-centred interventions tailored to comorbidity types. Targeted management of diabetes is instrumental in reducing the severity of comorbidities within the TCC pattern.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。